The Electronic Common Technical Document (eCTD) has transformed submissions to the Food and Drug Administration (FDA) and other regulatory authorities around the world. With the release of a new draft guidance in April 2015, and an update to M1 in June, the FDA is now enabling companies to submit their ad-promo submissions using eCTD, and soon this will shift to a mandatory submission. Join Veeva and Dale Cooke, of PhillyCooke Consulting, to learn more about this process and hear the latest updates from the FDA.